CVS Health Stock Price, News & Analysis (NYSE:CVS)

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, October 3rd. Investors of record on Thursday, October 24th will be paid a dividend of $0.50 per share on Monday, November 4th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.18%. The ex-dividend date of this dividend is Wednesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) announced its quarterly earnings data on Wednesday, August, 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating the Zacks' consensus estimate of $1.70 by $0.19. The pharmacy operator earned $63.43 billion during the quarter, compared to analysts' expectations of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The business's revenue for the quarter was up 35.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.69 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY19 earnings guidance on Wednesday, August, 7th. The company provided earnings per share (EPS) guidance of $6.89-7.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.84.

27 Wall Street analysts have issued 1-year price objectives for CVS Health's shares. Their forecasts range from $61.00 to $95.00. On average, they expect CVS Health's stock price to reach $75.39 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price. View Analyst Price Targets for CVS Health.

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 1 sell rating, 7 hold ratings, 18 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News stories about CVS stock have trended negative on Sunday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CVS Health earned a news sentiment score of -2.6 on InfoTrie's scale. They also assigned news headlines about the pharmacy operator a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Verizon Communications (VZ), Home Depot (HD), Intel (INTC) and Micron Technology (MU).

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Hexavest Inc. (0.09%), Artemis Investment Management LLP (0.05%), Country Trust Bank (0.04%), Cacti Asset Management LLC (0.04%), Polaris Greystone Financial Group LLC (0.04%) and Gillespie Robinson & Grimm Inc. (0.03%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Rothschild Investment Corp IL, State of Alaska Department of Revenue, Hexavest Inc., Verity & Verity LLC, TIAA FSB, Gyroscope Capital Management Group LLC, Crossmark Global Holdings Inc. and Community Trust & Investment Co.. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including Artemis Investment Management LLP, Polaris Greystone Financial Group LLC, Country Trust Bank, Hartwell J M Limited Partnership, Gillespie Robinson & Grimm Inc., Bogart Wealth LLC, Neville Rodie & Shaw Inc. and Altman Advisors Inc.. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $62.94.

CVS Health has a market capitalization of $81.85 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]